US Bancorp DE Has $49.34 Million Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• US Bancorp DE increased its stake in Intuitive Surgical by 40% during Q2, now holding 90,791 shares valued at approximately $49.34 million.
• Intuitive Surgical reported $2.19 earnings per share for its last quarter, beating analyst expectations of $1.93, with revenues up 21.4% year-over-year.
• Institutional investors own 83.64% of Intuitive Surgical’s stock, indicating strong confidence in the company's future performance.

US Bancorp DE grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 40.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,791 shares of the medical equipment provider's stock after buying an additional 25,927 shares during the period. US Bancorp DE's holdings in Intuitive Surgical were worth $49,337,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Aaron Wealth Advisors LLC increased its position in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock worth $1,374,000 after acquiring an additional 19 shares during the period. Crown Wealth Group LLC boosted its holdings in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after purchasing an additional 20 shares during the period. FSM Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after purchasing an additional 20 shares in the last quarter. CFO4Life Group LLC increased its holdings in shares of Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after purchasing an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC raised its position in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock valued at $741,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $443.76 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market capitalization of $159.08 billion, a PE ratio of 61.89, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61. The company has a fifty day moving average of $459.75 and a 200-day moving average of $498.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.78 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last quarter. 0.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ISRG shares. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Truist Financial upped their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wells Fargo & Company boosted their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. Finally, Piper Sandler reiterated an "overweight" rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.